Endoscopic retrograde cholangiopancreatography in pregnancy

P. A. Jamidar, G. J. Beck, B. J. Hoffman, Glen Lehman, R. H. Hawes, R. M. Agrawal, P. S. Ashok, T. J. Ravi, J. T. Cunningham, F. Troiano, Stuart Sherman, G. T. Brodmerkel

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Background: Pancreaticobiliary disease in pregnancy is relatively uncommon. The frequency of choledocholithiasis in pregnancy requiring intervention has been reported to be as low as one in 1200 deliveries. Traditionally, intervention in these patients has been surgical. Although surgery has an overall low morbidity and mortality for the expectant mother, it carries with it a 4- to 6-wk recovery period and a possibly increased risk of fetal wastage. Published information regarding the role and safety of ERCP in pregnancy is limited. This series of 23 pregnant patients undergoing ERCP was collected from six different medical centers. Methods: Twenty-three pregnant patients with symptomatic pancreaticobiliary disease underwent a total of 29 ERCPs (three patients had diagnostic ERCP, and 20 had therapeutic ERCP). Fifteen, eight, and six procedures were performed in the first, second, and third trimesters, respectively. The only ERCP complication was pancreatitis in one patient. There was one spontaneous abortion (3 months after ERCP) and one neonatal death; however, casual relationship to ERCP was not apparent. Conclusion: Diagnostic and therapeutic ERCP appears reasonably safe and effective in pregnancy. Cautious and selective use of this procedure offers a viable alternative to surgery or observation in patients with emergent pancreaticobiliary problems.

Original languageEnglish (US)
Pages (from-to)1263-1267
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume90
Issue number8
StatePublished - 1995

Fingerprint

Endoscopic Retrograde Cholangiopancreatography
Pregnancy
Choledocholithiasis
Third Pregnancy Trimester
Second Pregnancy Trimester
Spontaneous Abortion
First Pregnancy Trimester
Pancreatitis
Mothers
Observation
Morbidity
Safety
Mortality
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Jamidar, P. A., Beck, G. J., Hoffman, B. J., Lehman, G., Hawes, R. H., Agrawal, R. M., ... Brodmerkel, G. T. (1995). Endoscopic retrograde cholangiopancreatography in pregnancy. American Journal of Gastroenterology, 90(8), 1263-1267.

Endoscopic retrograde cholangiopancreatography in pregnancy. / Jamidar, P. A.; Beck, G. J.; Hoffman, B. J.; Lehman, Glen; Hawes, R. H.; Agrawal, R. M.; Ashok, P. S.; Ravi, T. J.; Cunningham, J. T.; Troiano, F.; Sherman, Stuart; Brodmerkel, G. T.

In: American Journal of Gastroenterology, Vol. 90, No. 8, 1995, p. 1263-1267.

Research output: Contribution to journalArticle

Jamidar, PA, Beck, GJ, Hoffman, BJ, Lehman, G, Hawes, RH, Agrawal, RM, Ashok, PS, Ravi, TJ, Cunningham, JT, Troiano, F, Sherman, S & Brodmerkel, GT 1995, 'Endoscopic retrograde cholangiopancreatography in pregnancy', American Journal of Gastroenterology, vol. 90, no. 8, pp. 1263-1267.
Jamidar PA, Beck GJ, Hoffman BJ, Lehman G, Hawes RH, Agrawal RM et al. Endoscopic retrograde cholangiopancreatography in pregnancy. American Journal of Gastroenterology. 1995;90(8):1263-1267.
Jamidar, P. A. ; Beck, G. J. ; Hoffman, B. J. ; Lehman, Glen ; Hawes, R. H. ; Agrawal, R. M. ; Ashok, P. S. ; Ravi, T. J. ; Cunningham, J. T. ; Troiano, F. ; Sherman, Stuart ; Brodmerkel, G. T. / Endoscopic retrograde cholangiopancreatography in pregnancy. In: American Journal of Gastroenterology. 1995 ; Vol. 90, No. 8. pp. 1263-1267.
@article{03a2942e0230426b8cb6c84977490196,
title = "Endoscopic retrograde cholangiopancreatography in pregnancy",
abstract = "Background: Pancreaticobiliary disease in pregnancy is relatively uncommon. The frequency of choledocholithiasis in pregnancy requiring intervention has been reported to be as low as one in 1200 deliveries. Traditionally, intervention in these patients has been surgical. Although surgery has an overall low morbidity and mortality for the expectant mother, it carries with it a 4- to 6-wk recovery period and a possibly increased risk of fetal wastage. Published information regarding the role and safety of ERCP in pregnancy is limited. This series of 23 pregnant patients undergoing ERCP was collected from six different medical centers. Methods: Twenty-three pregnant patients with symptomatic pancreaticobiliary disease underwent a total of 29 ERCPs (three patients had diagnostic ERCP, and 20 had therapeutic ERCP). Fifteen, eight, and six procedures were performed in the first, second, and third trimesters, respectively. The only ERCP complication was pancreatitis in one patient. There was one spontaneous abortion (3 months after ERCP) and one neonatal death; however, casual relationship to ERCP was not apparent. Conclusion: Diagnostic and therapeutic ERCP appears reasonably safe and effective in pregnancy. Cautious and selective use of this procedure offers a viable alternative to surgery or observation in patients with emergent pancreaticobiliary problems.",
author = "Jamidar, {P. A.} and Beck, {G. J.} and Hoffman, {B. J.} and Glen Lehman and Hawes, {R. H.} and Agrawal, {R. M.} and Ashok, {P. S.} and Ravi, {T. J.} and Cunningham, {J. T.} and F. Troiano and Stuart Sherman and Brodmerkel, {G. T.}",
year = "1995",
language = "English (US)",
volume = "90",
pages = "1263--1267",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Endoscopic retrograde cholangiopancreatography in pregnancy

AU - Jamidar, P. A.

AU - Beck, G. J.

AU - Hoffman, B. J.

AU - Lehman, Glen

AU - Hawes, R. H.

AU - Agrawal, R. M.

AU - Ashok, P. S.

AU - Ravi, T. J.

AU - Cunningham, J. T.

AU - Troiano, F.

AU - Sherman, Stuart

AU - Brodmerkel, G. T.

PY - 1995

Y1 - 1995

N2 - Background: Pancreaticobiliary disease in pregnancy is relatively uncommon. The frequency of choledocholithiasis in pregnancy requiring intervention has been reported to be as low as one in 1200 deliveries. Traditionally, intervention in these patients has been surgical. Although surgery has an overall low morbidity and mortality for the expectant mother, it carries with it a 4- to 6-wk recovery period and a possibly increased risk of fetal wastage. Published information regarding the role and safety of ERCP in pregnancy is limited. This series of 23 pregnant patients undergoing ERCP was collected from six different medical centers. Methods: Twenty-three pregnant patients with symptomatic pancreaticobiliary disease underwent a total of 29 ERCPs (three patients had diagnostic ERCP, and 20 had therapeutic ERCP). Fifteen, eight, and six procedures were performed in the first, second, and third trimesters, respectively. The only ERCP complication was pancreatitis in one patient. There was one spontaneous abortion (3 months after ERCP) and one neonatal death; however, casual relationship to ERCP was not apparent. Conclusion: Diagnostic and therapeutic ERCP appears reasonably safe and effective in pregnancy. Cautious and selective use of this procedure offers a viable alternative to surgery or observation in patients with emergent pancreaticobiliary problems.

AB - Background: Pancreaticobiliary disease in pregnancy is relatively uncommon. The frequency of choledocholithiasis in pregnancy requiring intervention has been reported to be as low as one in 1200 deliveries. Traditionally, intervention in these patients has been surgical. Although surgery has an overall low morbidity and mortality for the expectant mother, it carries with it a 4- to 6-wk recovery period and a possibly increased risk of fetal wastage. Published information regarding the role and safety of ERCP in pregnancy is limited. This series of 23 pregnant patients undergoing ERCP was collected from six different medical centers. Methods: Twenty-three pregnant patients with symptomatic pancreaticobiliary disease underwent a total of 29 ERCPs (three patients had diagnostic ERCP, and 20 had therapeutic ERCP). Fifteen, eight, and six procedures were performed in the first, second, and third trimesters, respectively. The only ERCP complication was pancreatitis in one patient. There was one spontaneous abortion (3 months after ERCP) and one neonatal death; however, casual relationship to ERCP was not apparent. Conclusion: Diagnostic and therapeutic ERCP appears reasonably safe and effective in pregnancy. Cautious and selective use of this procedure offers a viable alternative to surgery or observation in patients with emergent pancreaticobiliary problems.

UR - http://www.scopus.com/inward/record.url?scp=0029089581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029089581&partnerID=8YFLogxK

M3 - Article

VL - 90

SP - 1263

EP - 1267

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 8

ER -